Leveraging the species barrier to advance cancer therapy.

Publication Type:

Journal Article

Source:

Nature genetics, Volume 45, Issue 7, p.718-20 (2013)

Keywords:

2013, Center-Authored Paper, Clinical Research Division, Human Biology Division, July 2013

Abstract:

The discovery of new therapeutic targets and the personalization of treatments are two active areas of cancer research. New studies suggest that a 'co-clinical' approach may expedite both therapeutic target validation and risk stratification in patients with advanced prostate cancer.